Device Trial Radar · NCT04250857
HeartStart FRx Defibrillator Event Registry
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,400
Planned (sponsor's estimate)
Start
Nov 4, 2019
Primary completion
Dec 31, 2030
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Heartstream US LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 31, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
Summary
As written by the sponsor on the registry.
This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key. The registry is focused only on on post-event data collection and does not prescribe any device usage. This registry has several safeguards in place to prevent against selections bias, including enrollment of all participants who have pads placed. This registry will evaluate the safety and verify the clinical performance of the device in relation to its claims, when used in accordance with the Device Manual.
Conditions
- Sudden Cardiac Arrest
Interventions
HeartStart FRXDevice
Automated External Defibrillator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Algorithm accuracyTime frame: Up to 15 minutes after device placement
- Shock DeliveryTime frame: 1 day
- Unexpected adverse events.Time frame: 1 day
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Philips
Monroeville, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.